Head CT showed no intracranial hemorrhage or fracture.
CT chest on [**2134-11-16**] showed no focal pna, sputum neg for PCP, [**Name10 (NameIs) 103758**] negative, and AFB was neg x3.
He required 2 doses of neupogen for decreased cell counts and 2 blood transfusions.
CT chest at that time was negative but showed pleural effusions which were tapped and pt was started on lasix.
Repeat CXR was concerning for developing infiltrate and levaquin was continued for a total of 15 day course on [**2134-12-23**].
On [**2134-12-27**], per OMR notes, the patient spiked a fever of 101 with increased cough, productive of clear/whitish sputum.
CXR at the time showed interval development of a multilobar, right sided pna.
Repeat RSV washes were positive.
Additionally, blood cultures were positive for strep pneumo, pan sensitive.
Patient's pressures and vital signs have been stable, afebrile.
[**2135-1-6**] 09:30AM BLOOD WBC-6.2 RBC-2.62* Hgb-9.1* Hct-27.1* MCV-103* MCH-34.9* MCHC-33.8 RDW-17.4* Plt Ct-33* [**2135-1-6**] 09:30AM BLOOD Neuts-39* Bands-1 Lymphs-52* Monos-7 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-1* [**2135-1-6**] 09:30AM BLOOD PT-13.8* PTT-25.6 INR(PT)-1.2* [**2135-1-6**] 09:30AM BLOOD Plt Smr-VERY LOW Plt Ct-33* LPlt-1+ [**2135-1-6**] 09:30AM BLOOD Glucose-93 UreaN-21* Creat-0.9 Na-143 K-3.5 Cl-105 HCO3-29 AnGap-13 [**2135-1-7**] 04:20AM BLOOD ALT-16 AST-34 LD(LDH)-362* AlkPhos-79 Amylase-39 TotBili-2.8* DirBili-0.8* IndBili-2.0 [**2135-1-6**] 06:43PM BLOOD Calcium-8.6 Phos-4.8*# Mg-1.8 [**2135-1-6**] 05:50PM BLOOD Type-ART pO2-115* pCO2-51* pH-7.32* calTCO2-27 Base XS-0 Intubat-INTUBATED [**2135-1-6**] 05:50PM BLOOD Glucose-110* Lactate-3.6* Na-140 K-4.2 Cl-104 [**2135-1-6**] 05:50PM BLOOD Hgb-10.2* calcHCT-31 [**2135-1-6**] 05:50PM BLOOD freeCa-1.03* .
[**2135-2-10**] 12:32AM BLOOD WBC-5.9 RBC-2.67* Hgb-9.3* Hct-27.5* MCV-103* MCH-34.7* MCHC-33.6 RDW-22.9* Plt Ct-30* [**2135-2-9**] 01:17AM BLOOD Neuts-48* Bands-0 Lymphs-49* Monos-1* Eos-1 Baso-1 Atyps-0 Metas-0 Myelos-0 NRBC-4* [**2135-2-7**] 12:00AM BLOOD Gran Ct-2800 [**2135-2-10**] 12:32AM BLOOD Glucose-94 UreaN-18 Creat-0.6 Na-138 K-4.1 Cl-102 HCO3-29 AnGap-11 [**2135-2-10**] 12:32AM BLOOD ALT-8 AST-19 LD(LDH)-334* AlkPhos-132* TotBili-1.4 [**2135-1-19**] 12:00AM BLOOD proBNP-6544* [**2135-2-10**] 12:32AM BLOOD Calcium-9.5 Phos-2.2* Mg-2.1 [**2135-2-4**] 12:00AM BLOOD VitB12-1465* Folate-18.3 [**2135-1-22**] 11:00AM BLOOD TSH-7.3* [**2135-1-23**] 12:00AM BLOOD Free T4-1.3 [**2135-1-17**] 03:40PM BLOOD PTH-6* [**2135-1-14**] 06:15AM BLOOD ANCA-NEGATIVE B [**2135-1-11**] 07:30PM BLOOD ANCA-NEGATIVE B [**2135-1-14**] 06:15AM BLOOD [**Doctor First Name **]-NEGATIVE [**2135-1-11**] 07:30PM BLOOD [**Doctor First Name **]-NEGATIVE [**2135-1-22**] 11:00AM BLOOD VITAMIN D [**1-9**] DIHYDROXY- 10 [**2135-1-22**] 11:00AM BLOOD PARATHYROID HORMONE RELATED PROTEIN-PND at discharge [**2135-2-7**] 02:17PM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-12* Polys-2 Lymphs-89 Monos-0 Macroph-9 [**2135-2-7**] 02:17PM CEREBROSPINAL FLUID (CSF) TotProt-53* Glucose-61  CSF: No Malignant cells; No culture growth at discharge.
MRI Head: IMPRESSION: 1.
The patient was difficult to wean off the vent s/p ORIF, which was thought to be secondary to fluid overload and presence of RSV bronchiolitis and multifocal PNA.
He was diuresed and then underwent a CT Chest on [**1-10**], which showed an increase in multifocal lung nodules.
The patient was started on Meropenem and Voriconazole, and he underwent a bronchoscopy on [**2135-1-12**].
He will need a repeat B-Glucan and should stay on fluconisole for now until his B-Glucan is negative.
The patient had a CT of his abdomen on this admission, which showed an increase in his retroperitoneal lymphadenopathy.
His lymphocytes were elevated and so on [**2135-1-27**] the patient was given a dose of Rituxan.
During this admission, the patient was transfused platelets to maintain a count >50K intitially which eventually was weaned down to 10K while on Lovenox treatment.
His LP showed some atypical lymphocytes but there was not enough for flow.
He improved when his calcium went down and after the methotrexate.
Medications on Admission: Medications at home: -Acyclovir - 400 mg Tablet - 1 (One) Tablet(s) by mouth three times a day -Fentanyl - 25 mcg/hour Patch 72 hr - Change patch every 3 days  -Folate - (Dose adjustment - no new Rx) - 1 mg Tablet - 3 (Three) Tablet(s) by mouth once a day -Lasix - (Prescribed by Other Provider) - 40 mg Tablet - 0.5 (One half) Tablet(s) by mouth once a day -Nystatin - (Prescribed by Other Provider) - 100,000 unit/mL Suspension - 5 Suspension(s) by mouth four times a day as needed  -Oxycodone - (Dose adjustment - no new Rx) - 5 mg Capsule - 1 Capsule(s) by mouth q 4-6 hours as needed for pain -Protonix - 40 mg Tablet, Delayed Release (E.C.)
- 1 Tablet(s) by mouth once a day -Pentamidine - 300 mg Recon Soln - 300 mg inhaled every month for 6 months Diluted in 6 ml sterile water administered via aerosol  -Potassium Chloride - (Prescribed by Other Provider) - 10 mEq Capsule, Sustained Release - one Capsule(s) by mouth once a day  -Prednisone - (Prescribed by Other Provider) - 20 mg Tablet - 1.5 (One and a half) Tablet(s) by mouth DAILY (Daily) -Cyanocobalamin - 500 mcg Tablet - 2 Tablet(s) by mouth once a day -Docusate - (Prescribed by Other Provider) - 100 mg Capsule - 1 (One) Capsule(s) by mouth three times a day as needed for constipation -Senna - 8.6 mg Tablet - 2 (Two) Tablet(s) by mouth twice a day as needed for constipation -Atovaquone 750 mg/5 mL Suspension Ten (10) ml by mouth once a day.
Medications on transfer: Propofol 20-100 mcg/kg/min IV DRIP TITRATE TO Titrate to tolerate vent Chlorhexidine Gluconate 0.12% Oral Rinse 15 ml ORAL [**Hospital1 **] HYDROmorphone (Dilaudid) 0.2-0.6 mg IV Q5MIN:PRN PAIN Maximum total dose not to exceed 0.1 mg/kg.
Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: Right hip fracture.
Please return to the hospital or call your doctor if you have temperature greater than 100.4, shortness of breath, worsening difficulty with swallowing, chest pain, abdominal pain, diarrhea, or any other symptoms that you are concerned about.
Followup Instructions: Provider: [**Name10 (NameIs) **] XRAY (SCC 2) Phone:[**Telephone/Fax (1) 1228**] Date/Time:[**2135-3-29**] 8:40 Provider: [**First Name11 (Name Pattern1) 2191**] [**Last Name (NamePattern4) 2192**], [**MD Number(3) 1240**]:[**Telephone/Fax (1) 1228**] Date/Time:[**2135-3-29**] 9:00 Test for consideration post-discharge: Modified Acid-Fast stain for Nocardia  Outpatient lab: B-Glucan every 1-2 weeks until negative.
